Changes of apelin-13 concentration in patients with essential hypertension and extrasystole

dc.contributor.author	Ivankova, Anastasiia
dc.contributor.author	Kuzminova, Nataliia
dc.contributor.author	Ivanov, Valerii
dc.contributor.author	Lozinsky, Sergiy
dc.date.accessioned	2025-03-31T16:12:30Z
dc.date.available	2025-03-31T16:12:30Z
dc.date.issued	2022
dc.identifier.citation	Changes of apelin-13 concentration in patients with essential hypertension and extrasystole / Anastasiia V. Ivankova, Nataliia V.Kuzminova, Valerii P. Ivanov // Arterial hypertension – 2022. – 26(4)– P. 141-145	uk_UA
dc.identifier.issn	2449–6170
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/9362
dc.description.abstract	Hypertension is one of the leading causes of disability and mortality among cardiovascular diseases, so today new metabolic markers of cardiovascular risk are being actively studied. One of them is apelin-13. The objective was to assess the concentration of apelin-13 in patients with essential hypertension and frequent extrasystoles	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	Via Medica	uk_UA
dc.subject	essential arterial hypertension	uk_UA
dc.subject	apelin-13	uk_UA
dc.subject	extrasystole	uk_UA
dc.subject	smoking	uk_UA
dc.subject	obesity	uk_UA
dc.title	Changes of apelin-13 concentration in patients with essential hypertension and extrasystole	uk_UA
dc.type	Article	uk_UA